Iron management in patients using r-HuEPO.
Toffelmire
E B
EB
D000740:Anemia / Q000209:etiology / Q000628:therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005296:Ferrous Compounds / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications*
D005296:Ferrous Compounds; D004921:Erythropoietin